Skip to content

Investigator

Yanfang Su

UNIVERSITY OF WASHINGTON · funded by NHLBI

Companies
1

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$333k

Summed across those awards.

First award
Dec 14, 2023

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. K01

    Population strategies to reduce sodium intake and cardiovascular diseases in the United States: Applying RE-AIM to policy implementation

    $166k

    Dec 14, 2023NHLBIUNIVERSITY OF WASHINGTONNIH RePORTER · 11001235 (opens the source filing in a new tab)

  2. K01

    Population strategies to reduce sodium intake and cardiovascular diseases in the United States: Applying RE-AIM to policy implementation

    $166k

    Dec 14, 2023NHLBIUNIVERSITY OF WASHINGTONNIH RePORTER · 11323074 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources